We are live on ! Find out more
ATOS icon

Atossa Therapeutics

54 hedge funds and large institutions have $11.9M invested in Atossa Therapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

850% more call options, than puts

Call options by funds: $779K | Put options by funds: $82K

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

4% more funds holding

Funds holding: 5254 (+2)

0.01% more ownership

Funds ownership: 0.84%0.86% (+0.01%)

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

41% less capital invested

Capital invested by funds: $20.2M → $11.9M (-$8.26M)

Holders
54
Holders Change
+2
Holders Change %
+3.85%
% of All Funds
0.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
12
Reduced
15
Closed
6
Calls
$779K
Puts
$82K
Net Calls
+$697K
Net Calls Change
-$594K
Name Holding Trade Value Shares
Change
Change in
Stake
D.E. Shaw & Co
51
D.E. Shaw & Co
New York
-$273K -14,435 Closed
Wolverine Trading
52
Wolverine Trading
Illinois
-$18.1K -1,249 Closed
CAN
53
Cetera Advisor Networks
California
-$16.8K -889 Closed
BBA
54
Baader Bank Aktiengesellschaft
Germany
-$10.6K -724 Closed
DFCM
55
Dark Forest Capital Management
Puerto Rico
-$12.8K -680 Closed
Citigroup
56
Citigroup
New York
-$214 -11 Closed
Royal Bank of Canada
57
Royal Bank of Canada
Ontario, Canada
+$15 +1 +8%
NS
58
NBC Securities
Alabama
+$145 +10 New